Stephanie Oestreich, PhD
Stephanie Oestreich is a senior advisor at Orange Gove Bio. She is also currently the CBO at Galecto Biotech. Previously she was the Vice President at a cell therapy company called Mnemo Therapeutics. Prior to that, she was a Venture Partner at RA Capital and before that Executive Vice President at Evotec where she built up its North American investment arm and started an incubator with Samsara BioCapital.
She also worked as International Business Leader at F. Roche Hoffmann-La Roche Ltd., and for Novartis in Business Development and in Commercial in different geographies and therapeutics areas, successfully launching 6 drugs in immunology and oncology.
Stephanie conducted the research for her Ph.D. in biochemistry in the lab of a Nobel Prize winner at Harvard Medical School and obtained an MPA from the Harvard Kennedy School.
As a semi-professional violinist, she has performed with members of the Berlin, Vienna, and Boston Philharmonic Orchestra in Carnegie Hall and demonstrates the analogies of teams and leadership in music and management in presentations with the Kendall Square Orchestra, an orchestra of scientists that she co-founded: www.kendallsquareorchestra.org.